The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention.
The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention.
复制标题
DOI:
10.1186/2049-2618-2-14
复制
发表时间:
2014
期刊:
影响因子:
15.5
通讯作者:
O'Toole GA
中科院分区:
文献类型:
--
作者:
Hampton TH;Green DM;Cutting GR;Morrison HG;Sogin ML;Gifford AH;Stanton BA;O'Toole GA
Cystic fibrosis (CF) is caused by mutations in the CFTR gene that predispose the airway to infection. Chronic infection by pathogens such as Pseudomonas aeruginosa leads to inflammation that gradually degrades lung function, resulting in morbidity and early mortality. In a previous study of CF monozygotic twins, we demonstrate that genetic modifiers significantly affect the establishment of persistent P. aeruginosa colonization in CF. Recognizing that bacteria other than P. aeruginosa contribute to the CF microbiome and associated pathology, we used deep sequencing of sputum from pediatric monozygotic twins and nontwin siblings with CF to characterize pediatric bacterial communities and the role that genetics plays in their evolution. We found that the microbial communities in sputum from pediatric patients living together were much more alike than those from pediatric individuals living apart, regardless of whether samples were taken from monozygous twins or from nontwin CF siblings living together, which we used as a proxy for dizygous twins. In contrast, adult communities were comparatively monolithic and much less diverse than the microbiome of pediatric patients. Taken together, these data and other recent studies suggest that as patients age, the CF microbiome becomes less diverse, more refractory to treatment and dominated by mucoid P. aeruginosa, as well as being associated with accelerated pulmonary decline. Our studies show that the microbiome of pediatric patients is susceptible to environmental influences, suggesting that interventions to preserve the community structure found in young CF patients might be possible, perhaps slowing disease progression.
登录
查看更多内容
影响因子:
15.5
作者:
Price KE;Hampton TH;Gifford AH;Dolben EL;Hogan DA;Morrison HG;Sogin ML;O'Toole GA
通讯作者:
O'Toole GA
影响因子:
6.4
作者:
Madan JC;Koestler DC;Stanton BA;Davidson L;Moulton LA;Housman ML;Moore JH;Guill MF;Morrison HG;Sogin ML;Hampton TH;Karagas MR;Palumbo PE;Foster JA;Hibberd PL;O'Toole GA
通讯作者:
O'Toole GA
影响因子:
5.2
作者:
Gifford, Alex H.;Alexandru, Diana M.;O'Toole, George A.
通讯作者:
O'Toole, George A.
DOI:
10.1073/pnas.1120577109
发表时间:
2012-04-10
影响因子:
11.1
作者:
Zhao, Jiangchao;Schloss, Patrick D.;LiPuma, John J.
通讯作者:
LiPuma, John J.
影响因子:
5.1
作者:
Klepac-Ceraj, Vanja;Lemon, Katherine P.;Kolter, Roberto
通讯作者:
Kolter, Roberto